Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Malabsorption Syndromes D008286 16 associated lipids
Pregnancy Complications, Cardiovascular D011249 11 associated lipids
Thrombasthenia D013915 4 associated lipids
Gastrointestinal Hemorrhage D006471 27 associated lipids
Disseminated Intravascular Coagulation D004211 7 associated lipids
Shock, Traumatic D012774 4 associated lipids
Hemorrhagic Fever, American D006478 2 associated lipids
Fetal Growth Retardation D005317 9 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Arthus Reaction D001183 8 associated lipids
Thrombocytosis D013922 4 associated lipids
Toxemia D014115 3 associated lipids
Vitamin D Deficiency D014808 13 associated lipids
Duodenal Ulcer D004381 12 associated lipids
Angina Pectoris D000787 27 associated lipids
Angina, Unstable D000789 14 associated lipids
Pregnancy Complications, Hematologic D011250 11 associated lipids
Heart Defects, Congenital D006330 20 associated lipids
Klebsiella Infections D007710 7 associated lipids
Ascites D001201 25 associated lipids
Albuminuria D000419 18 associated lipids
Infant, Premature, Diseases D007235 7 associated lipids
Hyperinsulinism D006946 27 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Parkinson Disease D010300 53 associated lipids
Rhinitis, Allergic, Seasonal D006255 7 associated lipids
Salmonella Infections, Animal D012481 9 associated lipids
Bronchial Diseases D001982 3 associated lipids
Central Nervous System Diseases D002493 10 associated lipids
Tangier Disease D013631 8 associated lipids
Heart Arrest D006323 13 associated lipids
Cystitis D003556 23 associated lipids
Cholecystitis D002764 8 associated lipids
HIV Infections D015658 20 associated lipids
Subacute Sclerosing Panencephalitis D013344 3 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
AIDS Dementia Complex D015526 4 associated lipids
Constriction, Pathologic D003251 8 associated lipids
Medulloblastoma D008527 22 associated lipids
Zellweger Syndrome D015211 39 associated lipids
Coronary Thrombosis D003328 7 associated lipids
Glomerulonephritis, Membranous D015433 6 associated lipids
Peripheral Vascular Diseases D016491 8 associated lipids
Bronchopulmonary Dysplasia D001997 4 associated lipids
Hypertension, Portal D006975 12 associated lipids
Atherosclerosis D050197 85 associated lipids
Leukemia-Lymphoma, Adult T-Cell D015459 25 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Dyslexia D004410 3 associated lipids
Leukemia, Eosinophilic, Acute D015472 3 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Tomeo AC and Durán WN Resistance and exchange microvessels are modulated by different PAF receptors. 1991 Am. J. Physiol. pmid:1659229
Hines KL and Fisher RA Regulation of hepatic glycogenolysis and vasoconstriction during antigen-induced anaphylaxis. 1992 Am. J. Physiol. pmid:1375439
Livio M et al. Role of platelet-activating factor in primary hemostasis. 1988 Am. J. Physiol. pmid:2837916
Zimmerman BJ et al. Molecular determinants of lipid mediator-induced leukocyte adherence and emigration in rat mesenteric venules. 1994 Am. J. Physiol. pmid:8160832
Toyofuku T et al. Pulmonary vascular response to platelet-activating factor in conscious sheep. 1988 Am. J. Physiol. pmid:3414811
Huber W et al. Leukotriene B4 and C4 production in isolated rat gastric mucosal cells. 1993 Am. J. Physiol. pmid:8279553
Del Maschio A et al. Platelet activation by polymorphonuclear leukocytes exposed to chemotactic agents. 1990 Am. J. Physiol. pmid:2156456
Asako H et al. Phalloidin prevents leukocyte emigration induced by proinflammatory stimuli in rat mesentery. 1992 Am. J. Physiol. pmid:1362329
DeFily DV et al. PAF attenuates endothelium-dependent coronary arteriolar vasodilation. 1996 Am. J. Physiol. pmid:8764261
Xie J et al. Dissociation of TNF-alpha from endotoxin-induced nitric oxide and acute-phase hypotension. 1997 Am. J. Physiol. pmid:9249487
Martínez-Salgado C et al. Involvement of phospholipase A2 in gentamicin-induced rat mesangial cell activation. 1997 Am. J. Physiol. pmid:9249592
Munoz NM et al. Effects of PAF on isolated rat airways perfused with blood-free solution. 1991 Am. J. Physiol. pmid:2018147
Yamazaki M et al. Modulation of leukotriene B4 and platelet-activating factor binding to neutrophils. 1991 Am. J. Physiol. pmid:1653524
Hasunuma K et al. Endothelin 1 causes pulmonary vasodilation in rats. 1990 Am. J. Physiol. pmid:2115743
Schlondorff D et al. Production of platelet-activating factor in glomeruli and cultured glomerular mesangial cells. 1986 Am. J. Physiol. pmid:3087218
Wallace JL et al. Platelet-activating factor mediates gastric damage induced by hemorrhagic shock. 1990 Am. J. Physiol. pmid:2372058
Buerke M et al. Isolated cardiac myocytes are sensitized by hypoxia-reoxygenation to neutrophil-released mediators. 1994 Am. J. Physiol. pmid:8304493
Montrucchio G et al. Release of platelet-activating factor from ischemic-reperfused rabbit heart. 1989 Am. J. Physiol. pmid:2539755
Kurose I et al. Microvascular dysfunction induced by nonsteroidal anti-inflammatory drugs: role of leukocytes. 1996 Am. J. Physiol. pmid:8779980
Gozal D et al. Platelet-activating factor modulates cardiorespiratory responses in the conscious rat. 1998 Am. J. Physiol. pmid:9688699
Suzuki M et al. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets. 1998 Am. J. Physiol. pmid:9458712
Owen CA et al. Cytokines regulate membrane-bound leukocyte elastase on neutrophils: a novel mechanism for effector activity. 1997 Am. J. Physiol. pmid:9124593
Harris NR et al. Capillary filtration during acute inflammation: role of adherent neutrophils. 1993 Am. J. Physiol. pmid:7902014
Ardaillou N et al. Vasoconstrictor-evoked prostaglandin synthesis in cultured human mesangial cells. 1985 Am. J. Physiol. pmid:3918460
Ferrer-Lopez P et al. Activation of human platelets by C5a-stimulated neutrophils: a role for cathepsin G. 1990 Am. J. Physiol. pmid:2360620
Beyer AJ et al. PAF and CD18 mediate neutrophil infiltration in upper gastrointestinal tract during intra-abdominal sepsis. 1998 Am. J. Physiol. pmid:9724257
Handa RK et al. Platelet-activating factor is a renal vasodilator in the anesthetized rat. 1990 Am. J. Physiol. pmid:2360650
Eakes AT and Olson MS Regulation of endothelin synthesis in hepatic endothelial cells. 1998 Am. J. Physiol. pmid:9696707
Zhou W et al. Role of platelet-activating factor in hepatic responses after bile duct ligation in rats. 1992 Am. J. Physiol. pmid:1443133
Galens S et al. Assessment of agonist- and cell-mediated responses in airway microsections by computerized videomicrometry. 1995 Am. J. Physiol. pmid:7900832
Bussolino F et al. Platelet activating factor induces dopamine release in PC-12 cell line. 1988 Am. J. Physiol. pmid:3177629
Bienvenu K et al. Modulation of leukocyte migration in mesenteric interstitium. 1994 Am. J. Physiol. pmid:7943404
Lang CH et al. Platelet-activating factor-induced increases in glucose kinetics. 1988 Am. J. Physiol. pmid:3348371
Sun X et al. P-selectin-deficient mice are protected from PAF-induced shock, intestinal injury, and lethality. 1997 Am. J. Physiol. pmid:9252509
Saito M et al. Association of granular exocytosis with Ca(2+)-activated K+ channels in human eosinophils. 1997 Am. J. Physiol. pmid:9252535
Gulbins E et al. Effects of rC5a on the circulation of normal and split hydronephrotic rat kidneys. 1993 Am. J. Physiol. pmid:8342619
Rainger GE et al. Endothelial-borne platelet-activating factor and interleukin-8 rapidly immobilize rolling neutrophils. 1997 Am. J. Physiol. pmid:9038929
Sánchez-Crespo M et al. Presence in normal human urine of a hypotensive and platelet-activating phospholipid. 1983 Am. J. Physiol. pmid:6859262
Rabe KF et al. Contraction of human bronchial smooth muscle caused by activated human eosinophils. 1994 Am. J. Physiol. pmid:7943259
Dobrowsky RT et al. Effect of SRI 63-675 on hemodynamics and blood PAF levels during porcine endotoxemia. 1991 Am. J. Physiol. pmid:2035668
Kobayashi I et al. Platelet-activating factor modulates microvascular transport by stimulation of protein kinase C. 1994 Am. J. Physiol. pmid:8160825
Bellan JA et al. Analysis of pulmonary and systemic vascular responses to platelet-activating factor in the cat. 1992 Am. J. Physiol. pmid:1379004
Arnould T et al. Increased PMN adherence on endothelial cells after hypoxia: involvement of PAF, CD18/CD11b, and ICAM-1. 1993 Am. J. Physiol. pmid:8098907
Shibamoto T et al. PAF increases capillary pressure but not vascular permeability in isolated blood-perfused canine lungs. 1993 Am. J. Physiol. pmid:8498559
Miller MJ et al. SOD prevents damage and attenuates eicosanoid release in a rabbit model of necrotizing enterocolitis. 1988 Am. J. Physiol. pmid:2847541
Miura S et al. Attenuation of endotoxin-induced intestinal microcirculatory damage by eicosapentanoic acid. 1993 Am. J. Physiol. pmid:8498509
Huang Q et al. Neutrophil-dependent augmentation of PAF-induced vasoconstriction and albumin flux in coronary arterioles. 1998 Am. J. Physiol. pmid:9746460
Milhoan KA et al. Hypoxia induces endothelial cells to increase their adherence for neutrophils: role of PAF. 1992 Am. J. Physiol. pmid:1415623
Dorn GW and Davis MG Differential megakaryocytic desensitization to platelet agonists. 1992 Am. J. Physiol. pmid:1415671
Faden AI and Tzendzalian PA Platelet-activating factor antagonists limit glycine changes and behavioral deficits after brain trauma. 1992 Am. J. Physiol. pmid:1415805